Loading...
XJPX
7707
Market cap36mUSD
Jul 08, Last price  
197.00JPY
1D
1.03%
1Q
10.06%
Jan 2017
-51.60%
IPO
143.96%
Name

Precision System Science Co Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
1.35
EPS
—
Div Yield, %
—
Shrs. gr., 5y
2.42%
Rev. gr., 5y
-1.90%
Revenues
3.98b
-24.60%
3,397,932,0003,802,466,0005,637,771,0003,142,760,0003,520,274,0004,029,396,0003,921,722,0005,143,465,0004,458,411,0003,847,021,0003,641,164,0004,381,442,0005,067,231,0009,298,741,0007,434,287,0005,278,321,0003,979,954,000
Net income
-1.12b
L-15.31%
-400,557,00073,599,000549,992,000-366,678,000-189,057,0001,014,386,000611,958,000-215,220,000-1,582,050,000-555,218,000-457,616,000130,318,000-114,275,000795,985,00045,337,000-1,324,290,000-1,121,480,000
CFO
-107m
L+1,483.18%
199,351,000339,751,000407,281,000-403,391,000-396,598,000-35,239,000-822,599,000-1,362,603,00072,149,000-802,766,000-32,812,000-403,711,000-21,452,000-280,966,000869,161,000-6,746,000-106,801,000
Dividend
Jun 29, 20215 JPY/sh

Profile

Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products in Japan and internationally. The company manufactures and sells plastic consumables, which are used in automated systems/instruments, as well as reagents; and automated nucleic acid extraction and veterinary biochemical analysis systems. It also offers geneLEAD, an instrument for molecular testing; and engages in the research and development, and practical application of in vitro diagnosis testing market, including genetic and protein tests. Precision System Science Co., Ltd. was founded in 1985 and is headquartered in Matsudo, Japan.
URL
https://www.pss.co.jp/
IPO date
Feb 01, 2001
Employees
196
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
3,979,954
-24.60%
5,278,321
-29.00%
Cost of revenue
3,245,577
4,303,541
Unusual Expense (Income)
NOPBT
734,377
974,780
NOPBT Margin
18.45%
18.47%
Operating Taxes
19,077
48,389
Tax Rate
2.60%
4.96%
NOPAT
715,300
926,391
Net income
(1,121,480)
-15.31%
(1,324,290)
-3,020.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
(2)
(16)
BB yield
0.00%
0.00%
Debt
Debt current
1,076,960
1,344,143
Long-term debt
289,673
2,527,394
Deferred revenue
2,496
Other long-term liabilities
3,154
5,051
Net debt
(603,759)
1,266,180
Cash flow
Cash from operating activities
(106,801)
(6,746)
CAPEX
(12,000)
(155,285)
Cash from investing activities
2,056,789
(213,704)
Cash from financing activities
(2,508,350)
(154,054)
FCF
3,446,467
1,976,198
Balance
Cash
1,915,220
2,446,357
Long term investments
55,172
159,000
Excess cash
1,771,394
2,341,441
Stockholders' equity
(1,531,719)
4,091,196
Invested Capital
7,044,356
6,728,812
ROIC
10.39%
12.58%
ROCE
13.32%
10.74%
EV
Common stock shares outstanding
27,631
27,631
Price
190.00
-44.61%
343.00
-34.04%
Market cap
5,249,962
-44.61%
9,477,570
-34.04%
EV
4,646,203
10,743,750
EBITDA
1,143,458
1,616,007
EV/EBITDA
4.06
6.65
Interest
31,570
40,620
Interest/NOPBT
4.30%
4.17%